ImpediMed Limited

ASX:IPD.AX

0.05 (AUD) • At close September 16, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

202420232022202120202019201820172016201520142013201220112010200920082007
Revenue 10.31911.34410.5668.4095.7414.1563.3185.7665.7914.8443.5212.7332.9453.8873.6392.9922.3110
Cost of Revenue 24.29524.99823.91620.61118.6291.2520.9761.4891.5831.3240.9681.1741.2651.6561.6091.4270.6940
Gross Profit -13.976-13.654-13.35-12.202-12.8882.9042.3424.2774.2083.522.5531.5591.682.2312.031.5651.6180
Gross Profit Ratio -1.354-1.204-1.263-1.451-2.2450.6990.7060.7420.7270.7270.7250.570.570.5740.5580.5230.70
Reseach & Development Expenses 0.2210.5980.6831.4563.3083.3652.9645.3364.0411.0350.4010.5542.7831.3791.2652.9281.8280
General & Administrative Expenses 22.0955.3254.854.8654.6084.4956.9936.1077.7283.5253.0363.1197.61711.3698.0066.4754.6730
Selling & Marketing Expenses 0.5240.4580.6690.4470.8750.7140.8191.1951.2951.2960.4770.4540.7770.4990.1650.6460.4030
SG&A 9.7778.5947.1949.3599.31422.83429.67329.46628.48217.48210.05110.2578.39411.8688.1717.1215.0760
Other Expenses 3.0811.7031.6912.4374.1892.6963.063-0.560.0430.2650.010.7910.7770.0840.0520.0631.1210
Operating Expenses 9.9989.1927.87710.81512.62227.2229.97632.17530.34418.410.54510.21515.14517.48513.72215.7311.4570
Operating Income -23.974-22.846-21.227-23.017-25.51-26.96-30.712-30.78-28.499-15.145-8.011-9.447-13.465-15.254-11.692-14.165-9.8090
Operating Income Ratio -2.323-2.014-2.009-2.737-4.443-6.487-9.256-5.338-4.921-3.127-2.275-3.457-4.572-3.924-3.213-4.734-4.2440
Total Other Income Expenses Net 3.2490.77-0.220.5621.5753.0153.5063.2492.5190.3480.0760.9830.7770.0840.052-0.1361.1210
Income Before Tax -20.725-22.076-21.447-22.455-23.935-23.945-27.206-27.531-25.98-14.797-7.935-8.464-12.342-14.822-11.402-14.028-9.7540
Income Before Tax Ratio -2.008-1.946-2.03-2.67-4.169-5.762-8.2-4.775-4.486-3.055-2.254-3.097-4.191-3.813-3.133-4.688-4.220
Income Tax Expense -0.935-1.555-1.573-1.749-2.5580.0510.0420.04-2.348000-0.3460.0970.0530.0672.8090
Net Income -19.79-20.521-19.874-20.706-21.377-23.996-27.248-27.571-25.98-14.797-7.935-8.464-12.342-14.822-11.402-14.028-9.7540
Net Income Ratio -1.918-1.809-1.881-2.462-3.724-5.774-8.212-4.782-4.486-3.055-2.254-3.097-4.191-3.813-3.133-4.688-4.220
EPS -0.01-0.011-0.012-0.017-0.036-0.06-0.072-0.074-0.081-0.055-0.041-0.047-0.072-0.094-0.093-0.15-0.130
EPS Diluted -0.01-0.011-0.012-0.017-0.036-0.06-0.072-0.074-0.081-0.055-0.041-0.047-0.072-0.094-0.093-0.15-0.130
EBITDA -21.721-20.379-18.458-21.317-24.074-26.736-30.348-30.519-28.304-14.97-7.835-9.239-12.891-14.144-10.664-13.053-7.710
EBITDA Ratio -2.105-1.796-1.747-2.535-4.193-6.433-9.146-5.293-4.888-3.09-2.225-3.381-4.377-3.639-2.93-4.363-3.3360